Drug Profile
YH 14619
Alternative Names: Peniel-1000; YH14619Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Ensol Biosciences
- Class Small molecules
- Mechanism of Action Transforming growth factor beta receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Osteoarthritis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Osteoarthritis in South Korea
- 21 Aug 2012 Preclinical trials in Osteoarthritis in South Korea (unspecified route)